Annals of Neurology

Cover image for Annals of Neurology

Supplement: Research Issues in Position Emission Tomography

1984

Volume 15, Issue S1

Pages fmi–fmi, ii–ii, 1–204

  1. Masthead

    1. Top of page
    2. Masthead
    3. Preface
    4. Models and Technology Used in Positron Emission Tomography
    5. Original Articles
    6. Normal Physiology as Defined by Positron Emission Tomographys
    7. Positron Emission Tomography of Abnormal and Diseased States, I
    8. Positron Emission Tomography of Abnormal and Diseased States
    9. Positron Emission Tomography of Abnormal and Diseased States, I
    10. Positron Emission Tomography of Abnormal and Diseased States
    11. Positron Emission Tomography of Abnormal and Diseased States, I
    12. Positron Emission Tomography of Abnormal and Diseased States, II
    1. Masthead (page fmi)

      Version of Record online: 7 OCT 2004 | DOI: 10.1002/ana.410150701

  2. Preface

    1. Top of page
    2. Masthead
    3. Preface
    4. Models and Technology Used in Positron Emission Tomography
    5. Original Articles
    6. Normal Physiology as Defined by Positron Emission Tomographys
    7. Positron Emission Tomography of Abnormal and Diseased States, I
    8. Positron Emission Tomography of Abnormal and Diseased States
    9. Positron Emission Tomography of Abnormal and Diseased States, I
    10. Positron Emission Tomography of Abnormal and Diseased States
    11. Positron Emission Tomography of Abnormal and Diseased States, I
    12. Positron Emission Tomography of Abnormal and Diseased States, II
    1. Preface (page ii)

      Michael D. Walker

      Version of Record online: 7 OCT 2004 | DOI: 10.1002/ana.410150702

  3. Models and Technology Used in Positron Emission Tomography

    1. Top of page
    2. Masthead
    3. Preface
    4. Models and Technology Used in Positron Emission Tomography
    5. Original Articles
    6. Normal Physiology as Defined by Positron Emission Tomographys
    7. Positron Emission Tomography of Abnormal and Diseased States, I
    8. Positron Emission Tomography of Abnormal and Diseased States
    9. Positron Emission Tomography of Abnormal and Diseased States, I
    10. Positron Emission Tomography of Abnormal and Diseased States
    11. Positron Emission Tomography of Abnormal and Diseased States, I
    12. Positron Emission Tomography of Abnormal and Diseased States, II
    1. Modeling metabolic processes in the brain in vivo (pages 1–11)

      Dr. Louis Sokoloff

      Version of Record online: 7 OCT 2004 | DOI: 10.1002/ana.410150703

  4. Original Articles

    1. Top of page
    2. Masthead
    3. Preface
    4. Models and Technology Used in Positron Emission Tomography
    5. Original Articles
    6. Normal Physiology as Defined by Positron Emission Tomographys
    7. Positron Emission Tomography of Abnormal and Diseased States, I
    8. Positron Emission Tomography of Abnormal and Diseased States
    9. Positron Emission Tomography of Abnormal and Diseased States, I
    10. Positron Emission Tomography of Abnormal and Diseased States
    11. Positron Emission Tomography of Abnormal and Diseased States, I
    12. Positron Emission Tomography of Abnormal and Diseased States, II
    1. Emission tomographic measurement of local cerebral blood flow in humans by an in vivo autoradiographic strategy (pages 12–18)

      Myron D. Ginsberg, Bernard E. Howard and William R. Hassel

      Version of Record online: 7 OCT 2004 | DOI: 10.1002/ana.410150704

    2. Prospects for both precision and accuracy in positron emission tomography (pages 25–34)

      Edward J. Hoffman, Maurice van der Stee, Anthony R. Ricci and Michael E. Phelps

      Version of Record online: 7 OCT 2004 | DOI: 10.1002/ana.410150706

    3. Instrumentation for positron emission tomography (pages 35–43)

      Thomas F. Budinger, Stephen E. Derenzo and Ronald H. Huesman

      Version of Record online: 7 OCT 2004 | DOI: 10.1002/ana.410150707

    4. Summary of discussion: Models and technology used in positron emission tomography (pages 44–45)

      Dr Alfred P. Wolf and Thomas F. Budinger

      Version of Record online: 7 OCT 2004 | DOI: 10.1002/ana.410150708

  5. Normal Physiology as Defined by Positron Emission Tomographys

    1. Top of page
    2. Masthead
    3. Preface
    4. Models and Technology Used in Positron Emission Tomography
    5. Original Articles
    6. Normal Physiology as Defined by Positron Emission Tomographys
    7. Positron Emission Tomography of Abnormal and Diseased States, I
    8. Positron Emission Tomography of Abnormal and Diseased States
    9. Positron Emission Tomography of Abnormal and Diseased States, I
    10. Positron Emission Tomography of Abnormal and Diseased States
    11. Positron Emission Tomography of Abnormal and Diseased States, I
    12. Positron Emission Tomography of Abnormal and Diseased States, II
    1. Dynamic cerebral positron emission tomographic studies (pages 46–47)

      Dr Michel M. Ter-Pogossian, David C. Ficke, Mark A. Mintun, Peter Herscovitch, Peter T. Fox and Marcus E. Raichle

      Version of Record online: 7 OCT 2004 | DOI: 10.1002/ana.410150709

    2. Dynamic measurements of local blood flow and metabolism in the study of higher cortical function in humans with positron emission tomography (pages 48–49)

      Dr Marcus E. Raichle, Peter Herscovitch, Mark A. Mintun, W. R. Wayne Martin and William Powers

      Version of Record online: 7 OCT 2004 | DOI: 10.1002/ana.410150710

    3. Positron emission tomographic studies of perceptual tasks (pages 61–65)

      M. Reivich, A. Alavi and R. C. Gur

      Version of Record online: 7 OCT 2004 | DOI: 10.1002/ana.410150712

    4. Measurements in vivo of parameters of the dopamine system (pages 66–76)

      Dr A. M. Friedman, O. T. Dejesus, J. Revenaugh and R. J. Dinerstein

      Version of Record online: 7 OCT 2004 | DOI: 10.1002/ana.410150713

    5. [18F]spiroperidol: A radiopharmaceutical for the in vivo study of the dopamine receptor (pages 77–78)

      Michael J. Welch, Marcus E. Raichle, Michael R. Kilbourn and Mark A. Mintun

      Version of Record online: 7 OCT 2004 | DOI: 10.1002/ana.410150714

    6. Assessment of dopamine receptor densities in the human brain with carbon-11-labeled N-methylspiperone (pages 79–84)

      Henry N. Wagner Jr, H. Donald Burns, Robert F. Dannals, Dean F. Wong, Bengt Langström, Timothy Duelfer, J. James Frost, Hayden T. Ravert, Jonathan M. Links, Shelley B. Rosenbloom, Scott E. Lukas, Alfred V. Kramer and Michael J. Kuhar

      Version of Record online: 7 OCT 2004 | DOI: 10.1002/ana.410150715

    7. In vivo studies of opiate receptors (pages 85–92)

      J. James Frost, Robert F. Dannals, Timothy Duelfer, H. Donald Burns, Hayden T. Ravert, Bengt Langströ, V. Balasubramanian and Henry N. Wagner Jr

      Version of Record online: 7 OCT 2004 | DOI: 10.1002/ana.410150716

    8. A regional metabolic contrast method for the study of brain pathology (pages 93–97)

      Bernard W. Agranoff and Kirk A. Frey

      Version of Record online: 7 OCT 2004 | DOI: 10.1002/ana.410150717

    9. In vivo measurement of regional brain tissue pH using positron emission tomography (pages 98–102)

      D. A. Rottenberg, J. Z. Ginos, K. J. Kearfott, L. Junck and D. D. Bigner

      Version of Record online: 7 OCT 2004 | DOI: 10.1002/ana.410150718

    10. Radiation absorbed dose to tracheal mucosa from inhaled oxygen-15-labeled carbon dioxide (pages 107–109)

      G. F. Powell, R. A. Schuchard, C. S. Reft and P. V. Harper

      Version of Record online: 7 OCT 2004 | DOI: 10.1002/ana.410150720

    11. Summary of discussion: Normal physiology as defined by positron emission tomography (pages 110–111)

      Dr Henry N. Wagner Jr. and J. James Frost

      Version of Record online: 7 OCT 2004 | DOI: 10.1002/ana.410150721

  6. Positron Emission Tomography of Abnormal and Diseased States, I

    1. Top of page
    2. Masthead
    3. Preface
    4. Models and Technology Used in Positron Emission Tomography
    5. Original Articles
    6. Normal Physiology as Defined by Positron Emission Tomographys
    7. Positron Emission Tomography of Abnormal and Diseased States, I
    8. Positron Emission Tomography of Abnormal and Diseased States
    9. Positron Emission Tomography of Abnormal and Diseased States, I
    10. Positron Emission Tomography of Abnormal and Diseased States
    11. Positron Emission Tomography of Abnormal and Diseased States, I
    12. Positron Emission Tomography of Abnormal and Diseased States, II
    1. Positron emission tomographic studies in aging and cerebrovascular disease at hammersmith hospital (pages 112–118)

      Richard S. J. Frackowiak, Richard J. S. Wise, Jeremy M. Gibbs and Terry Jones

      Version of Record online: 7 OCT 2004 | DOI: 10.1002/ana.410150722

    2. Patterns of cerebral glucose utilization in Parkinson's disease and Huntington's disease (pages 119–125)

      Dr David E. Kuhl, E. Jeffrey Metter, Walter H. Riege and Charles H. Markham

      Version of Record online: 7 OCT 2004 | DOI: 10.1002/ana.410150723

  7. Positron Emission Tomography of Abnormal and Diseased States

    1. Top of page
    2. Masthead
    3. Preface
    4. Models and Technology Used in Positron Emission Tomography
    5. Original Articles
    6. Normal Physiology as Defined by Positron Emission Tomographys
    7. Positron Emission Tomography of Abnormal and Diseased States, I
    8. Positron Emission Tomography of Abnormal and Diseased States
    9. Positron Emission Tomography of Abnormal and Diseased States, I
    10. Positron Emission Tomography of Abnormal and Diseased States
    11. Positron Emission Tomography of Abnormal and Diseased States, I
    12. Positron Emission Tomography of Abnormal and Diseased States, II
    1. Positron imaging in ischemic stroke disease (pages 126–130)

      Dr Robert H. Ackerman, Nathaniel M. Alpert, John A. Correia, Seth Finklestein, Stephen M. Davis, Roger E. Kelley, Geoffrey A. Donnan, Joseph G. D'Alton and Juan M. Taveras

      Version of Record online: 7 OCT 2004 | DOI: 10.1002/ana.410150724

    2. Parkinson's disease: Metabolic and pharmacological approaches with positron emission tomography (pages 131–132)

      Marcus E. Raichle, Joel S. Perlmutter and Peter T. Fox

      Version of Record online: 7 OCT 2004 | DOI: 10.1002/ana.410150725

  8. Positron Emission Tomography of Abnormal and Diseased States, I

    1. Top of page
    2. Masthead
    3. Preface
    4. Models and Technology Used in Positron Emission Tomography
    5. Original Articles
    6. Normal Physiology as Defined by Positron Emission Tomographys
    7. Positron Emission Tomography of Abnormal and Diseased States, I
    8. Positron Emission Tomography of Abnormal and Diseased States
    9. Positron Emission Tomography of Abnormal and Diseased States, I
    10. Positron Emission Tomography of Abnormal and Diseased States
    11. Positron Emission Tomography of Abnormal and Diseased States, I
    12. Positron Emission Tomography of Abnormal and Diseased States, II
    1. The effect of normal aging on patterns of local cerebral glucose utilization (pages 133–137)

      David E. Kuhl, E. Jeffrey Metter, Walter H. Riege and Randall A. Hawkins

      Version of Record online: 7 OCT 2004 | DOI: 10.1002/ana.410150726

  9. Positron Emission Tomography of Abnormal and Diseased States

    1. Top of page
    2. Masthead
    3. Preface
    4. Models and Technology Used in Positron Emission Tomography
    5. Original Articles
    6. Normal Physiology as Defined by Positron Emission Tomographys
    7. Positron Emission Tomography of Abnormal and Diseased States, I
    8. Positron Emission Tomography of Abnormal and Diseased States
    9. Positron Emission Tomography of Abnormal and Diseased States, I
    10. Positron Emission Tomography of Abnormal and Diseased States
    11. Positron Emission Tomography of Abnormal and Diseased States, I
    12. Positron Emission Tomography of Abnormal and Diseased States, II
    1. Issues in the in vivo measurement of glucose metabolism of human central nervous system tumors (pages 138–146)

      Giovanni di Chiro, Rodney A. Brooks, Nicholas J. Patronas, Dikran Bairamian, Paul L. Kornblith, Barry H. Smith, Luigi Mansi and John Barker

      Version of Record online: 7 OCT 2004 | DOI: 10.1002/ana.410150727

  10. Positron Emission Tomography of Abnormal and Diseased States, I

    1. Top of page
    2. Masthead
    3. Preface
    4. Models and Technology Used in Positron Emission Tomography
    5. Original Articles
    6. Normal Physiology as Defined by Positron Emission Tomographys
    7. Positron Emission Tomography of Abnormal and Diseased States, I
    8. Positron Emission Tomography of Abnormal and Diseased States
    9. Positron Emission Tomography of Abnormal and Diseased States, I
    10. Positron Emission Tomography of Abnormal and Diseased States
    11. Positron Emission Tomography of Abnormal and Diseased States, I
    12. Positron Emission Tomography of Abnormal and Diseased States, II
  11. Positron Emission Tomography of Abnormal and Diseased States, II

    1. Top of page
    2. Masthead
    3. Preface
    4. Models and Technology Used in Positron Emission Tomography
    5. Original Articles
    6. Normal Physiology as Defined by Positron Emission Tomographys
    7. Positron Emission Tomography of Abnormal and Diseased States, I
    8. Positron Emission Tomography of Abnormal and Diseased States
    9. Positron Emission Tomography of Abnormal and Diseased States, I
    10. Positron Emission Tomography of Abnormal and Diseased States
    11. Positron Emission Tomography of Abnormal and Diseased States, I
    12. Positron Emission Tomography of Abnormal and Diseased States, II
    1. Positron emission tomographic study of affective disorders: Problems and strategies (pages 149–156)

      Michael E. Phelps, John C. Mazziotta, Lewis Baxter and Robert Gerner

      Version of Record online: 7 OCT 2004 | DOI: 10.1002/ana.410150729

    2. Positron emission tomographic image measurement in schizophrenia and affective disorders (pages 157–169)

      Monte S. Buchsbaum, J. Cappelletti, Ron Ball, E. Hazlett, A. C. King, J. Johnson, J. Wu and Lynn E. Delisi

      Version of Record online: 7 OCT 2004 | DOI: 10.1002/ana.410150730

    3. Patterns of metabolic activity in the treatment of schizophrenia (pages 166–169)

      Dr. Jonathan D. Brodie, David R. Christman, Juan F. Corona, Joanna S. Fowler, Francisco Gomez-Mont, Judith Jaeger, Peter A. Micheels, John Rotrosen, Jerome A. Russell, Nora D. Volkow, Alan Wikler, Alfred P. Wolf and Adam Wolkin

      Version of Record online: 7 OCT 2004 | DOI: 10.1002/ana.410150731

    4. Regional cortical dysfunction in Alzheimer's disease as determined by positron emission tomography (pages 170–174)

      Dr. Thomas N. Chase, Norman L. Foster, Paul Fedio, Rodney Brooks, Luigi Mansi and Giovanni di Chiro

      Version of Record online: 7 OCT 2004 | DOI: 10.1002/ana.410150732

    5. Gilles de la tourette syndrome: Studies with the fluorine-18-labeled fluorodeoxyglucose positron emission tomographic method (page 175)

      Dr. Thomas N. Chase, Norman L. Foster, Paul Fedio, Rodney Brooks, Luigi Mansi, Robert Kessler and Giovanni di Chiro

      Version of Record online: 7 OCT 2004 | DOI: 10.1002/ana.410150733

    6. The role of positron emission tomography in the evaluation of seizure disorders (pages 176–179)

      William H. Theodore, Rodney Brooks, Susumu Sato, Nicholas Patronas, Richard Margolin, Giovanni di Chiro and Roger J. Porter

      Version of Record online: 7 OCT 2004 | DOI: 10.1002/ana.410150734

    7. Criteria for the tracer kinetic measurement of cerebral protein synthesis in humans with positron emission tomography (pages 192–202)

      M. E. Phelps, J. R. Barrio, S-C. Huang, R. E. Keen, H. Chugani and J. C. Mazziotta

      Version of Record online: 7 OCT 2004 | DOI: 10.1002/ana.410150736

SEARCH

SEARCH BY CITATION